AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials.
J. Armisen, Mitra Rauschecker, Janeli Sarv, Mathias Liljeblad +22 more
2025Journal of Hepatology63 citations Open access
Semantic Scholar

